{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T12:47:55Z","timestamp":1774270075903,"version":"3.50.1"},"reference-count":48,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2010,7,7]],"date-time":"2010-07-07T00:00:00Z","timestamp":1278460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytopathology"],"published-print":{"date-parts":[[2010,8]]},"abstract":"<jats:p>K. Sigurdsson\u2028<jats:bold>Cervical cancer: cytological cervical screening in Iceland and implications of HPV vaccines<\/jats:bold><\/jats:p><jats:p>This paper reviews the Icelandic experience regarding the age\u2010specific effectiveness, optimal targeted age range and intervals in cervical cancer screening and the screening implications of the HPV16\/18 vaccines. The background material is based on data from a screening programme with centralized records dating back to 1964, as well as from population\u2010based studies on the distribution of oncogenic HPV types in cancer and histologically verified CIN2\u20103 lesions and from the Icelandic arm of the Future II trial with Gardasil<jats:sup>\u00ae<\/jats:sup>. The findings confirm significant increased rates in the screened population of CIN2\u20103, stage IA (microinvasive) cancer since 1979, mainly in the age group 20\u201334\u2003years. These lesions start to accumulate within 3\u2003years of a normal smear. Studies on the distribution of HPV types indicate that the marketed vaccines could lower the incidence of cancer and CIN2\u20103 by about 67% and 53%, respectively, after taking into account reported cross\u2010protection. About 65% of women below 25\u2003years of age had lesions related to the non\u2010vaccine types and after the last normal smear these cases accumulated at the same frequency as cases with vaccine\u2010included types. Cases with combined vaccine and non\u2010vaccine types accumulated at a slower rate. We conclude that screening should continue to start at age 20\u2003years, with invitations at 2\u2010year intervals up to age 39\u2003years and thereafter at 4\u2010year intervals up to age 65\u201369\u2003years. Current data support the conclusion that the optimal age for catch\u2010up HPV vaccination should be considered in the context of sexual practices and the data do not support changes in the lower age limit or screening intervals for the vaccinated women.<\/jats:p>","DOI":"10.1111\/j.1365-2303.2010.00783.x","type":"journal-article","created":{"date-parts":[[2010,7,7]],"date-time":"2010-07-07T14:49:42Z","timestamp":1278514182000},"page":"213-222","source":"Crossref","is-referenced-by-count":16,"title":["Cervical cancer: cytological cervical screening in Iceland and implications of HPV vaccines"],"prefix":"10.1111","volume":"21","author":[{"given":"K.","family":"Sigurdsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,7,7]]},"reference":[{"key":"e_1_2_7_2_2","volume-title":"GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide","author":"Ferlay J","year":"2004"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.55.4.244"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.5858\/2003-127-930-HPEAPH"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jncimonographs.a003476"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1048-891X.2004.014505.x"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2004.12.008"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jncimonographs.a003479"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20244"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16674-9"},{"key":"e_1_2_7_11_2","first-page":"661","article-title":"A survey of the actualities and potentialities of exofoliative cytology in cancer diagnosis","volume":"30","author":"Papanicolaou GN","year":"1948","journal-title":"Ann Med"},{"key":"e_1_2_7_12_2","first-page":"7","article-title":"Current concepts of intraepithelial neoplasia in uterine cervix","volume":"5","author":"Koss LG","year":"1987","journal-title":"Appl Pathol"},{"key":"e_1_2_7_13_2","unstructured":"RichartRM.Cervical intraepithelial neoplasia. In: Sommers SC.Patholo Annu1973;8:301\u201328."},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.3.252"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4612-2042-8"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2303.2007.00469.x"},{"key":"e_1_2_7_17_2","first-page":"239","volume-title":"Handbooks of Cancer Prevention","author":"IARC","year":"2005"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5122(85)90029-5"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0412.1999.780602.x"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061741"},{"key":"e_1_2_7_21_2","first-page":"1","article-title":"Impact of human papillomavirus (HPV)\u20106\/11\/16\/18 vaccine on all HPV\u2010associated genital diseases in young women","volume":"102","author":"Mu\u00f1oz N","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68439-0"},{"key":"e_1_2_7_23_2","first-page":"65","article-title":"A human papillomavirus vaccine","volume":"48","author":"Anonymous","year":"2006","journal-title":"Med Lett Drug Ther"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1086\/597307"},{"key":"e_1_2_7_25_2","unstructured":"GardnerMJ AltmanDG eds.Statistics with confidence \u2013 confidence intervals and statistical guidelines. London:BMJ Books.1989."},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910540408"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0412.1999.780603.x"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2006.11.017"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1080\/00016340500432457"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1080\/00016340500432481"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1080\/00016340500432465"},{"key":"e_1_2_7_32_2","first-page":"677","article-title":"Management of patients with two consecutive ASC\u2010US smears","volume":"6","author":"Bekkers RLM","year":"2004","journal-title":"Eur J Gynaec Oncol"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a1284"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2968"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mop.0000133078.40007.2b"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.admecli.2004.03.001"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19990825)87:4<184::AID-CNCR4>3.0.CO;2-#"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.103.3.539"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1086\/522863"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.18995-0"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990924)83:1<59::AID-IJC12>3.0.CO;2-N"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.6.781"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh104"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23034"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1080\/00016340802566770"},{"key":"e_1_2_7_46_2","first-page":"16","article-title":"Cervical cancer screening effectiveness and implications of HPV vaccines","volume":"64","author":"Sigurdsson K","year":"2007","journal-title":"European Magazine on Sexual and Reproductive Health-Entre Nous-WHO publication"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0412.2003.00086.x"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a842"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990315)80:6<818::AID-IJC4>3.0.CO;2-T"}],"container-title":["Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2303.2010.00783.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2303.2010.00783.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T03:45:55Z","timestamp":1698637555000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2303.2010.00783.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,7]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["10.1111\/j.1365-2303.2010.00783.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2303.2010.00783.x","archive":["Portico"],"relation":{},"ISSN":["0956-5507","1365-2303"],"issn-type":[{"value":"0956-5507","type":"print"},{"value":"1365-2303","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,7]]}}}